Nov 7, 2025 | Glass Pharms
This article was originally published by LBC. Companies and MPs have said legal cannabis cultivators could provide a ‘huge opportunity’ for economic growth and health benefits In the Wiltshire countryside, an unsuspecting looking greenhouse emerges at the top of a...
Feb 17, 2024 | Glass Pharms
This article was originally published in The Guardian. For 26 years, Olivier Dehon worked in the corporate sector, ending up as chief financial officer for Xerox in the UK and Ireland before retiring four years ago. Last month he delivered his first consignment of...
Oct 30, 2023 | Glass Pharms
PRESS RELEASE Monday October 30th For immediate release 1st November this year marks five years since the UK government legalised cannabis-based products for medicinal use in 2018 and figures released by the Home Office this week have shown that the amount of...
Jan 18, 2023 | Glass Pharms
Glass Pharms are supporting a Health Economics Analysis study conducted by the University of York that will examine the potential economic cost benefits if cannabis-based medicines were prescribed to chronic pain patients on the NHS. The research will include a...
Sep 21, 2022 | Glass Pharms
LONDON, Sept. 21, 2022 /PRNewswire/ — Having secured up to £26.7M of funding from a FTSE-250 listed investment fund, Glass Pharms, the UK-based medical cannabis cultivation company, are delighted to announce a team of best-of-breed partners to complete their...
